Kevin E. Weddington

Array ( [id] => 3525350 [patent_doc_number] => 05504084 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-02 [patent_title] => 'Pharmaceutical for the treatment of skin disorders' [patent_app_type] => 1 [patent_app_number] => 8/216332 [patent_app_country] => US [patent_app_date] => 1994-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2674 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/504/05504084.pdf [firstpage_image] =>[orig_patent_app_number] => 216332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688239 [patent_doc_number] => 05643902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Veterinary treatment' [patent_app_type] => 1 [patent_app_number] => 8/214653 [patent_app_country] => US [patent_app_date] => 1994-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 888 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643902.pdf [firstpage_image] =>[orig_patent_app_number] => 214653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3109125 [patent_doc_number] => 05464636 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-07 [patent_title] => 'Biocidal methods and compositions for recirculating water systems' [patent_app_type] => 1 [patent_app_number] => 8/212287 [patent_app_country] => US [patent_app_date] => 1994-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 16302 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/464/05464636.pdf [firstpage_image] =>[orig_patent_app_number] => 212287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3487704 [patent_doc_number] => 05474989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Drug composition' [patent_app_type] => 1 [patent_app_number] => 8/203863 [patent_app_country] => US [patent_app_date] => 1994-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 29 [patent_no_of_words] => 4800 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/474/05474989.pdf [firstpage_image] =>[orig_patent_app_number] => 203863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3519721 [patent_doc_number] => 05529994 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'Treatment for toxoplasmosis' [patent_app_type] => 1 [patent_app_number] => 8/203539 [patent_app_country] => US [patent_app_date] => 1994-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 10245 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/529/05529994.pdf [firstpage_image] =>[orig_patent_app_number] => 203539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3961116 [patent_doc_number] => 05900435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-04 [patent_title] => 'Composition, food product and uses of 3-guanidinopropionic acid' [patent_app_type] => 1 [patent_app_number] => 8/196250 [patent_app_country] => US [patent_app_date] => 1994-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7311 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/900/05900435.pdf [firstpage_image] =>[orig_patent_app_number] => 196250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3724199 [patent_doc_number] => 05681816 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure' [patent_app_type] => 1 [patent_app_number] => 8/122468 [patent_app_country] => US [patent_app_date] => 1994-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4936 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681816.pdf [firstpage_image] =>[orig_patent_app_number] => 122468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622786 [patent_doc_number] => 05594007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Method for treating spinal cord trauma with phenolic 2-piperidino-1-alkanols' [patent_app_type] => 1 [patent_app_number] => 8/195797 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6049 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 249 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/594/05594007.pdf [firstpage_image] =>[orig_patent_app_number] => 195797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3497296 [patent_doc_number] => 05532274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Orally administerable drugs for the treatment of central dopamine deficiency conditions' [patent_app_type] => 1 [patent_app_number] => 8/090163 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2216 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532274.pdf [firstpage_image] =>[orig_patent_app_number] => 090163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661229 [patent_doc_number] => 05648355 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin' [patent_app_type] => 1 [patent_app_number] => 8/193597 [patent_app_country] => US [patent_app_date] => 1994-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5524 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648355.pdf [firstpage_image] =>[orig_patent_app_number] => 193597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3535330 [patent_doc_number] => 05494660 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'Method for inhibiting microbial binding to surfaces' [patent_app_type] => 1 [patent_app_number] => 8/194209 [patent_app_country] => US [patent_app_date] => 1994-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 25612 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494660.pdf [firstpage_image] =>[orig_patent_app_number] => 194209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3522489 [patent_doc_number] => 05489579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-06 [patent_title] => 'Potentation of NMDA antagonists' [patent_app_type] => 1 [patent_app_number] => 8/191996 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4107 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/489/05489579.pdf [firstpage_image] =>[orig_patent_app_number] => 191996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3524917 [patent_doc_number] => 05527788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent' [patent_app_type] => 1 [patent_app_number] => 8/184191 [patent_app_country] => US [patent_app_date] => 1994-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 27 [patent_no_of_words] => 6420 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527788.pdf [firstpage_image] =>[orig_patent_app_number] => 184191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590273 [patent_doc_number] => 05585399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Method of protecting cells and tissues by a triacylglycerol preparation' [patent_app_type] => 1 [patent_app_number] => 8/183538 [patent_app_country] => US [patent_app_date] => 1994-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4587 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585399.pdf [firstpage_image] =>[orig_patent_app_number] => 183538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3554349 [patent_doc_number] => 05519042 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-21 [patent_title] => 'Method of treating hyperproliferative vascular disease' [patent_app_type] => 1 [patent_app_number] => 8/181116 [patent_app_country] => US [patent_app_date] => 1994-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2747 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/519/05519042.pdf [firstpage_image] =>[orig_patent_app_number] => 181116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3486760 [patent_doc_number] => RE035233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Method of treating catabolic dysfunction' [patent_app_type] => 2 [patent_app_number] => 8/180780 [patent_app_country] => US [patent_app_date] => 1994-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17074 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/035/RE035233.pdf [firstpage_image] =>[orig_patent_app_number] => 180780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688025 [patent_doc_number] => 05643886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Avermectins and milbemycins to treat parasitic infestations in dogs' [patent_app_type] => 1 [patent_app_number] => 8/064080 [patent_app_country] => US [patent_app_date] => 1994-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2487 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 539 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643886.pdf [firstpage_image] =>[orig_patent_app_number] => 064080 [rel_patent_id] =>[rel_patent_doc_number] =>)